Acumen Pharmaceuticals (NASDAQ:ABOS) Releases Earnings Results, Misses Expectations By $0.02 EPS

Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.02), Zacks reports. During the same period last year, the firm posted ($0.28) earnings per share. Acumen Pharmaceuticals Stock Performance Shares of ABOS stock […]

Related Keywords

,News Ratings For Acumen Pharmaceuticals Daily ,Earnings History For Acumen Pharmaceuticals ,Acumen Pharmaceuticals Stock Performance ,Acumen Pharmaceuticals Company Profile ,Acumen Pharmaceuticals Inc ,Acumen Pharmaceuticals ,Get Free Report ,Acumen Pharmaceuticals Daily ,